BackVerastem Overview

Verastem Total Liabilities

Verastem's total liabilities is $150M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$146.03M
11.03% YoYΔ $-18.10M vs prior year quarter

Peer average

Loading

Verastem Total Liabilities History

Loading

Verastem vs. peers: Total Liabilities Comparison

Loading

Verastem Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Verastem (VSTM) FAQ

As of the most recent data (March 2026), VSTM shows a total liabilities of $150M. That compares with $160M in the prior-year period — down 11.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, VSTM's total liabilities is now $150M (was $160M) — a 11.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Verastem is outperforming or lagging.

Tracking VSTM's total liabilities over time shows whether Verastem is scaling, shrinking, or reshaping that part of the business. The current reading is $150M That compares with $160M in the prior-year period — down 11.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Verastem's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $150M) with ownership activity and broader fundamentals.

Verastem's total liabilities is $150M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.